Higher Plasma Pentraxin-3 Level Predicts Adverse Clinical Outcomes in Patients With Coronary Artery Disease: A Meta-Analysis of Cohort Studies

Background: Association between plasma pentraxin-3 (PTX-3) and clinical outcomes in patients with coronary artery disease (CAD) remains not fully determined. An updated meta-analysis of cohort studies was performed to systematically evaluate the association. Methods: Cohort studies evaluating the as...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Kejun, Shi, Zhewei, Qian, Caizhen, Yang, Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785244/
https://www.ncbi.nlm.nih.gov/pubmed/35083296
http://dx.doi.org/10.3389/fcvm.2021.726289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785244/
https://www.ncbi.nlm.nih.gov/pubmed/35083296
http://dx.doi.org/10.3389/fcvm.2021.726289

Ejemplares similares